HCM
MED icon

Highbridge Capital Management’s Medifast MED Stock Holding History

Highbridge Capital Management’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-3,000
Closed -$210K – 1500
2017
Q4 		$210K Buy
+3,000
New +$199K ﹤0.01% 1476
2014
Q4 		– Sell
-34,100
Closed -$1.12M – 1326
2014
Q3 		$1.12M Sell
34,100
-39,300
-54% -$1.21M 0.01% 624
2014
Q2 		$2.23M Buy
+73,400
New +$2.29M 0.03% 399

Other funds holding MED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Highbridge Capital Management's MED Position: Q1 2018 in Review

Highbridge Capital Management sold out of Medifast (MED) in Q1 2018, closing a stake of 2,991 shares — an estimated $209K sold.

Highbridge Capital Management first reported a position in MED in Q2 2013 and held it in 5 quarters. The position peaked at $897K in Q1 2017. 225 funds tracked by Wall St. Rank hold MED as of Q1 2018.

  • Highbridge Capital Management reported no remaining Medifast position as of Q1 2018 after selling out during the quarter.
  • Highbridge Capital Management sold 2,991 Medifast shares in Q1 2018, an estimated $209K.
  • Highbridge Capital Management first reported a position in Medifast in Q2 2013 and held it in 5 quarters.
  • Highbridge Capital Management's Medifast position peaked at $897K in Q1 2017.
  • 225 funds tracked by Wall St. Rank held Medifast as of Q1 2018.

Based on Highbridge Capital Management's 13F filing for Q1 2018, filed 15 May 2018.